Reider Paul has filed 8 insider transactions across 1 company since January 2024.
Most recent transaction: a tax payment of 4858 shares of Coherus Oncology, Inc. ($CHRS) on January 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2025 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | F | Common Stock | 4858 | $1.39 | 82,069.0000 | 114,553,537 | 5.59% | 0.00% |
| Jan. 4, 2025 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | F | Common Stock | 2277 | $1.66 | 86,927.0000 | 114,553,537 | 2.55% | 0.00% |
| Jan. 3, 2025 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 114,553,537 | 9999.99% | 0.14% |
| Dec. 13, 2024 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | F | Common Stock | 2073 | $1.61 | 89,204.0000 | 115,210,091 | 2.27% | 0.00% |
| July 22, 2024 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 114,819,965 | 9999.99% | 0.03% |
| Jan. 20, 2024 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | F | Common Stock | 4854 | $2.44 | 81,277.0000 | 94,162,637 | 5.64% | 0.01% |
| Jan. 4, 2024 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | F | Common Stock | 2275 | $2.92 | 86,131.0000 | 94,162,637 | 2.57% | 0.00% |
| Jan. 2, 2024 | Coherus Oncology, Inc. | $CHRS | Reider Paul | Chief Commercial Officer | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 94,162,637 | 9999.99% | 0.17% |